Calculate Your Monthly Mounjaro Treatment Cost
Current Monthly Cost Breakdown by Dose
Your monthly Mounjaro cost depends on your prescribed dose and ordering frequency. Starting doses of 2.5mg cost £129.99 for your first order, then £144.99 monthly for returning customers. Higher maintenance doses like 10mg cost £229.99 initially, then £244.99 monthly. These prices include clinical assessment and UK delivery from our GPhC-registered pharmacy.
Smart Budgeting with Bundle Options
Our bundle packs reduce monthly costs during dose escalation. The Intro Trio bundle covers your first 12 weeks at £534.99 (first order price), averaging £178.33 monthly versus £219.99 buying individually. This prescription-only treatment requires gradual dose increases, making bundles ideal for consistent monthly budgeting while you titrate to your maintenance dose.
First Order Savings Impact Monthly Costs
New customers save £40 on first orders, significantly reducing initial monthly treatment costs. Your first 2.5mg pen costs just £129.99 instead of £169.99. This saving helps offset initial consultation costs and makes starting treatment more affordable. Returning customers still save £25 on every order, keeping ongoing monthly costs manageable throughout treatment.
Long-term Monthly Cost Planning
Most patients reach maintenance doses of 10mg-15mg after titration. Budget £244.99-£293.99 monthly for returning customer maintenance costs. These prescription-only injections require consistent weekly use alongside reduced-calorie diet and exercise. Our payment plans spread costs across the month, making higher doses financially manageable for sustained treatment success.
Order Now and Lock in Current Prices
Treatment costs may vary with market changes, but ordering now secures current pricing. Clinical assessment takes 3 working days, or upgrade to express 24-hour approval. This MHRA-regulated treatment activates GIP and GLP-1 hormones to support appetite regulation. Start your assessment today and begin budgeting for consistent monthly treatment at locked-in prices.
